US EditionStudy Explores How Ocrelizumab Alters Immune System by Targeting CD20-Positive B Cells in Multiple Sclerosis
Summary by GeneOnline News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Study Explores How Ocrelizumab Alters Immune System by Targeting CD20-Positive B Cells in Multiple Sclerosis
A recent study has provided new insights into how ocrel […] The post Study Explores How Ocrelizumab Alters Immune System by Targeting CD20-Positive B Cells in Multiple Sclerosis first appeared on GeneOnline News. The post Study Explores How Ocrelizumab Alters Immune System by Targeting CD20-Positive B Cells in Multiple Sclerosis appeared first on GeneOnline News.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
